Related Experiment Video
Updated: Dec 14, 2025
04:53
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
1.2K
Obstructive sleep apnea in pulmonary fibrosis
Sophia E Schiza1, Izolde Bouloukaki1, Maria Bolaki2
1Department of Respiratory Medicine, Sleep Disorders Center, University General Hospital, Medical School of the University of Crete.
Current Opinion in Pulmonary Medicine
|July 24, 2020
Summary
Obstructive sleep apnea (OSA) is a common condition in interstitial lung diseases (ILDs), particularly idiopathic pulmonary fibrosis (IPF). Early diagnosis and treatment of OSA can improve sleep, quality of life, and outcomes for ILD patients.
Area of Science:
- Pulmonary Medicine
- Sleep Medicine
- Respiratory Diseases
Background:
- Limited prior research on sleep disorders in interstitial lung diseases (ILDs).
- Physicians historically overlooked sleep disorders like obstructive sleep apnea (OSA) in ILD patients.
- Growing recent interest in OSA's impact on ILDs, especially idiopathic pulmonary fibrosis (IPF).
Purpose of the Study:
- To review recent evidence on OSA in ILDs, focusing on IPF.
- To summarize OSA prevalence, presentation, complications, and diagnosis in ILDs.
- To explore the role of OSA therapy in improving patient outcomes.
Main Methods:
- Review of recent scientific literature on OSA and ILDs.
- Analysis of data on OSA prevalence and clinical impact in IPF.
- Evaluation of evidence regarding OSA treatment efficacy in ILD patients.
Main Results:
- OSA is a high-prevalence comorbidity in IPF.
- Recent evidence highlights OSA's effect on sleep, quality of life, and outcomes in ILDs.
- Therapy for OSA shows potential to improve sleep and quality of life in ILD patients.
Conclusions:
- More research is needed to fully understand the OSA-ILD association.
- Increased physician awareness is crucial for early OSA diagnosis in ILD patients.
- Characterizing OSA and ILDs as an 'overlap' syndrome requires further investigation.
More Related Videos
Related Concept Videos
01:21Sleep Apnea
369
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
369
01:17Other Pulmonary Disorders
1.4K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.4K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.0K
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
481
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
481
01:22Chronic Obstructive Pulmonary Disease
2.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
01:30Pulmonary Hypertension: Classification and Pathogenesis
472
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
472